CTRI/2020/08/027160尚未招募未知
A double blinded, randomized, controlled, monocentric study toevaluate and compare the immediate anti-dandruff efficacy of the test shampoo (Dabur Vatika Germ Protection Shampoo -BNo.02/150)
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male or female subjects in general good health.
- •2. Subjects in the age group 18-50 years (both the ages inclusive).
- •3. Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4. Subjects with moderate dandruff score of >20 or above of adherent and non adherent dandruff on each lateral side (total dandruff severity scale) and with visible flakes
- •5. Subjects willing to abide by and comply with the study protocol.
- •6. Subjects who agree to refrain from using any hair product (including shampoo and hair oil) for 48 hours post hair wash
排除标准
- •1. Subjects having any active scalp disease which may interfere in the studyâ??dermatologistâ??s judgement.
- •2. Female subjects who are known to be pregnant
- •3. Subjects with frizzy hair that may influence in the scoring of dandruff
- •4. Subjects with significant white hair influencing the scoring of dandruff
- •5. Subjects who have had hair transplant.
- •6. Subjects who have taken any systemic drug containing corticoids, or anti-fungal, or antibiotics, or any prolonged use of topical drug containing Corticosteroid, or anti-fungal,
- •or antibiotics, or any prolonged use of non-steroidal anti-inflammatory, or
- •anti-histaminic within 2 weeks prior to the study;
- •7. Any history of underlying uncontrolled medical illness including diabetes mellitus,
- •hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness
研究者
相似试验
尚未招募
1 期
To compare the pharmacokinetics of the test product recombinant asparaginase with the reference product Spectrila® in healthy, adult, subjects.CTRI/2024/05/068025Gennova Biopharmaceuticals Limited
尚未招募
不适用
ltrasonic waves for healing of patients with diabetic foot ulcerCTRI/2017/09/009785MASER ELECTRONICS PVT LTD SPONSORED CLINICAL TRIA
已完成
不适用
Safety and Efficacy of Loxoprofen Sodium cataplasm Ointment Against Knee OsteoarthritisMusculoskeletal DiseasesGonarthrosis [arthrosis of knee]Knee osteoarthritisISRCTN40097939ead Chemical Co. Ltd (Japan)160
已完成
不适用
Safety and Efficacy of Loxoprofen Sodium cataplasm Ointment Against Swelling and Pain caused By Trauma (SELSOASPBT)ISRCTN10182003ead Chemical Co. Ltd (Japan)160
尚未招募
不适用
A randomized, double-blind, double-dummy, single dose, 4-way cross-over study to develop an anti-cholinergic pharmacological challenge with mecamylamine in comparison to scopolamineAlzheimermental deterioration10029305NL-OMON37435Centre for Human Drug Research12
